Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$126.10 USD
+1.56 (1.25%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $126.01 -0.09 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INSP 126.10 +1.56(1.25%)
Will INSP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSP
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Misses Revenue Estimates
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Doximity (DOCS) Reports Next Week: Wall Street Expects Earnings Growth
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy?
Other News for INSP
Uncovering Potential: Inspire Medical Systems's Earnings Preview
Inspire Medical Systems Q2 2025 Earnings Preview
Baron Discovery Fund Q2 2025 Commentary
TimesSquare Global Small Cap Strategy Q2 2025 Commentary
Apnimed says sleep apnea drug meets primary endpoint in Phase 3 trial